Figure 2.

(a), (b), (c), and (d): imaging before intravitreal bevacizumab. (e), (f), (g), and (h): imaging after intravitreal bevacizumab. (a), (c), (e), and (g): infrared imaging shows macular position of OCT scanner at infra-red picture. Serous neuroretinal detachment is well evident in both vertical and horizontal scansion, before (b, d) and after bevacizumab injection (f, h). Presumed focal defect in RPE corresponding to the active leaking point is indicated by the pink arrow. Amount of serous fluid (white arrow) leaking from underling RPE-choriocapillary layer is tomographically unchanged.